Recent News

Share
and/or

Connect with us

82 News Items found
In the Lab
CAR T cells attacking cancer
CRISPR Genome-Editing Tool Takes Cancer Immunotherapy to the Next Level

What do you get when you combine two of the hottest areas of biotechnology? A new paper from MSK researchers explains.
Feature
Barry Taylor
With MSK Leading the Way, Precision Medicine Links Lab Research to Patient Care

Therapies that target genetic alterations in tumors are showing promise for many cancer patients, but challenges in developing these new treatments remain.
In the News
Vice President Joe Biden led a roundtable “cancer moonshot” discussion at Memorial Sloan Kettering
Between the Moon and New York City: Vice President Biden Leads MSK Cancer Moonshot Roundtable

Find out what Vice President Joe Biden had to say when he visited MSK for a roundtable “cancer moonshot” discussion.
Announcement
Dr. Joan Massagué, Sloan Kettering Institute Director received the Pezcoller Foundation-AACR International Award for Cancer Research and was named an AACR fellow at AACR16.
News from #AACR16: Targeted Therapy Breakthrough, Improved Survival in Melanoma, and Benefits of Gut Bugs

Long-awaited results of clinical trials testing targeted drugs and immunotherapy combinations were on offer at the annual American Association for Cancer Research (AACR) conference.
In the Lab
a sneaky man on a sneaky mission
Stealth Mode: How Metastatic Cancer Cells Evade Detection by the Immune System

Cancer cells have a sneaky ability to hide out in the body for years at a time. MSK scientists are looking for ways to flush them out.
In the Lab
photo of Foxo1 protein stained in regulatory T cells
In the Fight against Cancer, the Immune System Can Be a Double-Edged Sword

The immune system is a powerful tool for fighting cancer — sometimes too powerful.
In the Lab
MSK investigators Joan Massagué and Anna Obenauf
Outsmarting Cancer’s Survival Skills

A new study led by MSK investigators reveals how some cancer cells become resistant to targeted treatment and suggests what might be done to stop that from happening.
In the Clinic
Pictured: Charles Sawyers
The Evolution of a Lifesaving Drug: A Scientist Reflects

Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.
In the Clinic
New treatments developed at MSK focus on both common and rare cancers.
Report Highlights Advances Made at MSK That Are Changing Patients’ Lives

An annual report from an influential cancer group highlights three MSK studies that have advanced cancer research.
In the Lab
Stained pathology slides of a patient’s tumor (right) and of an organoid made from that tumor (left).
Five Fascinating Approaches to Cancer Science

From tropical plants and 3-D snapshots of worms to tiny particles that light up tumors, here’s a glimpse at some of the fascinating work MSK researchers pursued in 2014 as part of our quest to advance cancer science.